Prognostic significance of advanced lung cancer inflammation index (ALI) In untreated and treated stage IV non-small cell lung cancer (NSCLC): An Australian cancer centre experience
Hiren Mandaliya(Lake Macquarie Private Hospital), Ina Nordman(Calvary Mater Newcastle Hospital), Christopher Oldmeadow(Hunter Medical Research Institute), Mark Jones(Hunter Medical Research Institute)
Cited by 1
Related Papers
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits
|Nature Genetics|2018|1.5k
Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders
|The American Journal of Human Genetics|2018|453
Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)
|Translational Lung Cancer Research|2019|392
Multiethnic meta-analysis identifies ancestry-specific and cross-ancestry loci for pulmonary function
|Nature Communications|2018|130
A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration
|Human Molecular Genetics|2015|103